Beauty Health (SKIN) Competitors

$0.64 -0.03 (-4.90%)

Closing price 05/15/2026 04:00 PM Eastern

Extended Trading

$0.64 +0.00 (+0.20%)

As of 05/15/2026 04:10 PM Eastern

SKIN vs. TLSI, SI, SGHT, CARL, and PROF

Should you buy Beauty Health stock or one of its competitors? MarketBeat compares Beauty Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Beauty Health include TriSalus Life Sciences (TLSI), Shoulder Innovations (SI), Sight Sciences (SGHT), Carlsmed (CARL), and Profound Medical (PROF). These companies are all part of the "medical equipment" industry.

How does Beauty Health compare to TriSalus Life Sciences?

TriSalus Life Sciences (NASDAQ:TLSI) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

In the previous week, TriSalus Life Sciences and TriSalus Life Sciences both had 7 articles in the media. Beauty Health's average media sentiment score of 0.90 beat TriSalus Life Sciences' score of -0.12 indicating that Beauty Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TriSalus Life Sciences	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Beauty Health	3 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

TriSalus Life Sciences presently has a consensus price target of $7.50, suggesting a potential upside of 179.85%. Beauty Health has a consensus price target of $2.32, suggesting a potential upside of 260.42%. Given Beauty Health's higher probable upside, analysts clearly believe Beauty Health is more favorable than TriSalus Life Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TriSalus Life Sciences	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

TriSalus Life Sciences has a beta of 0.56, indicating that its stock price is 44% less volatile than the broader market. Comparatively, Beauty Health has a beta of 1.12, indicating that its stock price is 12% more volatile than the broader market.

Beauty Health has a net margin of -2.03% compared to TriSalus Life Sciences' net margin of -60.85%. TriSalus Life Sciences' return on equity of 0.00% beat Beauty Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TriSalus Life Sciences	-60.85%	N/A	-69.91%
Beauty Health	-2.03%	-9.38%	-1.21%

2.6% of TriSalus Life Sciences shares are owned by institutional investors. Comparatively, 93.3% of Beauty Health shares are owned by institutional investors. 16.3% of TriSalus Life Sciences shares are owned by insiders. Comparatively, 40.3% of Beauty Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Beauty Health has higher revenue and earnings than TriSalus Life Sciences. Beauty Health is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TriSalus Life Sciences	$45.15M	3.64	-$39.23M	-$1.41	N/A
Beauty Health	$300.80M	0.28	-$9.52M	-$0.17	N/A

Summary

Beauty Health beats TriSalus Life Sciences on 10 of the 15 factors compared between the two stocks.

How does Beauty Health compare to Shoulder Innovations?

Beauty Health (NASDAQ:SKIN) and Shoulder Innovations (NYSE:SI) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

In the previous week, Shoulder Innovations had 2 more articles in the media than Beauty Health. MarketBeat recorded 9 mentions for Shoulder Innovations and 7 mentions for Beauty Health. Beauty Health's average media sentiment score of 0.90 beat Shoulder Innovations' score of 0.35 indicating that Beauty Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beauty Health	3 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Shoulder Innovations	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Beauty Health presently has a consensus target price of $2.32, suggesting a potential upside of 260.42%. Shoulder Innovations has a consensus target price of $21.00, suggesting a potential upside of 33.09%. Given Beauty Health's higher possible upside, equities analysts clearly believe Beauty Health is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Beauty Health has a net margin of -2.03% compared to Shoulder Innovations' net margin of -81.78%. Beauty Health's return on equity of -9.38% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beauty Health	-2.03%	-9.38%	-1.21%
Shoulder Innovations	-81.78%	-35.11%	-20.58%

93.3% of Beauty Health shares are owned by institutional investors. 40.3% of Beauty Health shares are owned by insiders. Comparatively, 29.0% of Shoulder Innovations shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Beauty Health has higher revenue and earnings than Shoulder Innovations. Beauty Health is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beauty Health	$300.80M	0.28	-$9.52M	-$0.17	N/A
Shoulder Innovations	$47.32M	6.92	-$40.36M	-$166.96	N/A

Summary

Beauty Health beats Shoulder Innovations on 10 of the 15 factors compared between the two stocks.

How does Beauty Health compare to Sight Sciences?

Beauty Health (NASDAQ:SKIN) and Sight Sciences (NASDAQ:SGHT) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.

Beauty Health has higher revenue and earnings than Sight Sciences. Sight Sciences is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beauty Health	$300.80M	0.28	-$9.52M	-$0.17	N/A
Sight Sciences	$77.36M	3.50	-$38.43M	-$0.71	N/A

Beauty Health has a beta of 1.12, indicating that its stock price is 12% more volatile than the broader market. Comparatively, Sight Sciences has a beta of 2.38, indicating that its stock price is 138% more volatile than the broader market.

In the previous week, Beauty Health had 3 more articles in the media than Sight Sciences. MarketBeat recorded 7 mentions for Beauty Health and 4 mentions for Sight Sciences. Sight Sciences' average media sentiment score of 1.02 beat Beauty Health's score of 0.90 indicating that Sight Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beauty Health	3 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sight Sciences	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Beauty Health presently has a consensus target price of $2.32, suggesting a potential upside of 260.42%. Sight Sciences has a consensus target price of $8.31, suggesting a potential upside of 66.92%. Given Beauty Health's higher possible upside, research analysts plainly believe Beauty Health is more favorable than Sight Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Sight Sciences	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.44

Beauty Health has a net margin of -2.03% compared to Sight Sciences' net margin of -46.83%. Beauty Health's return on equity of -9.38% beat Sight Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beauty Health	-2.03%	-9.38%	-1.21%
Sight Sciences	-46.83%	-52.34%	-28.49%

93.3% of Beauty Health shares are owned by institutional investors. Comparatively, 55.5% of Sight Sciences shares are owned by institutional investors. 40.3% of Beauty Health shares are owned by insiders. Comparatively, 28.9% of Sight Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Beauty Health beats Sight Sciences on 11 of the 16 factors compared between the two stocks.

How does Beauty Health compare to Carlsmed?

Beauty Health (NASDAQ:SKIN) and Carlsmed (NASDAQ:CARL) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.

Beauty Health has higher revenue and earnings than Carlsmed. Carlsmed is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beauty Health	$300.80M	0.28	-$9.52M	-$0.17	N/A
Carlsmed	$50.51M	5.92	-$29.63M	-$2.51	N/A

In the previous week, Beauty Health had 6 more articles in the media than Carlsmed. MarketBeat recorded 7 mentions for Beauty Health and 1 mentions for Carlsmed. Carlsmed's average media sentiment score of 1.89 beat Beauty Health's score of 0.90 indicating that Carlsmed is being referred to more favorably in the news media.

Company	Overall Sentiment
Beauty Health	Positive
Carlsmed	Very Positive

Beauty Health presently has a consensus target price of $2.32, suggesting a potential upside of 260.42%. Carlsmed has a consensus target price of $19.33, suggesting a potential upside of 75.60%. Given Beauty Health's higher possible upside, research analysts plainly believe Beauty Health is more favorable than Carlsmed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Beauty Health has a net margin of -2.03% compared to Carlsmed's net margin of -57.76%. Beauty Health's return on equity of -9.38% beat Carlsmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beauty Health	-2.03%	-9.38%	-1.21%
Carlsmed	-57.76%	-60.74%	-29.84%

93.3% of Beauty Health shares are owned by institutional investors. 40.3% of Beauty Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Beauty Health beats Carlsmed on 11 of the 15 factors compared between the two stocks.

How does Beauty Health compare to Profound Medical?

Profound Medical (NASDAQ:PROF) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

In the previous week, Beauty Health had 4 more articles in the media than Profound Medical. MarketBeat recorded 7 mentions for Beauty Health and 3 mentions for Profound Medical. Beauty Health's average media sentiment score of 0.90 beat Profound Medical's score of 0.82 indicating that Beauty Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Profound Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Beauty Health	3 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

47.9% of Profound Medical shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 1.5% of Profound Medical shares are held by company insiders. Comparatively, 40.3% of Beauty Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profound Medical has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market. Comparatively, Beauty Health has a beta of 1.12, indicating that its share price is 12% more volatile than the broader market.

Profound Medical currently has a consensus target price of $12.00, indicating a potential upside of 72.17%. Beauty Health has a consensus target price of $2.32, indicating a potential upside of 260.42%. Given Beauty Health's higher probable upside, analysts plainly believe Beauty Health is more favorable than Profound Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Beauty Health has a net margin of -2.03% compared to Profound Medical's net margin of -206.76%. Beauty Health's return on equity of -9.38% beat Profound Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Profound Medical	-206.76%	-78.88%	-64.06%
Beauty Health	-2.03%	-9.38%	-1.21%

Beauty Health has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profound Medical	$16.10M	15.73	-$42.57M	-$1.24	N/A
Beauty Health	$300.80M	0.28	-$9.52M	-$0.17	N/A

Summary

Beauty Health beats Profound Medical on 13 of the 14 factors compared between the two stocks.

Get Beauty Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SKIN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SKIN vs. The Competition

Export

Metric	Beauty Health	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$83.42M	$8.17B	$6.38B	$12.30B
Dividend Yield	N/A	3.06%	2.81%	5.30%
P/E Ratio	-3.79	21.86	20.62	25.25
Price / Sales	0.28	16.45	554.93	75.55
Price / Cash	4.21	12.21	27.48	37.27
Price / Book	1.34	4.79	9.80	6.71
Net Income	-$9.52M	$183.43M	$3.57B	$336.00M
7 Day Performance	10.98%	-1.16%	0.23%	0.12%
1 Month Performance	-29.47%	-1.15%	-2.54%	-0.18%
1 Year Performance	-63.01%	-0.37%	33.54%	30.62%

Beauty Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SKIN Beauty Health	2.2844 of 5 stars	$0.64 -4.9%	$2.32 +260.4%	-63.0%	$83.42M	$300.80M	N/A	1,030	Gap Down
TLSI TriSalus Life Sciences	2.0004 of 5 stars	$4.62 +1.7%	$7.00 +51.7%	-47.9%	$282.95M	$45.15M	N/A	106	News Coverage Analyst Forecast
SI Shoulder Innovations	4.0153 of 5 stars	$13.28 +0.4%	$21.00 +58.2%	N/A	$273.84M	$47.32M	N/A	61	News Coverage Earnings Report
SGHT Sight Sciences	4.3187 of 5 stars	$4.87 -8.4%	$8.31 +70.9%	+40.3%	$265.63M	$77.36M	N/A	210
CARL Carlsmed	3.226 of 5 stars	$9.76 +1.0%	$19.33 +98.1%	N/A	$265.28M	$50.51M	N/A	100

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SKIN) was last updated on 5/17/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Beauty Health (SKIN) Competitors

SKIN vs. TLSI, SI, SGHT, CARL, and PROF

How does Beauty Health compare to TriSalus Life Sciences?

Summary

How does Beauty Health compare to Shoulder Innovations?

Summary

How does Beauty Health compare to Sight Sciences?

Summary

How does Beauty Health compare to Carlsmed?

Summary

How does Beauty Health compare to Profound Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKIN vs. The Competition

Beauty Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Beauty Health (SKIN) Competitors

SKIN vs. TLSI, SI, SGHT, CARL, and PROF

How does Beauty Health compare to TriSalus Life Sciences?

Does the media refer more to TLSI or SKIN?

Do analysts recommend TLSI or SKIN?

Which has more volatility & risk, TLSI or SKIN?

Is TLSI or SKIN more profitable?

Do institutionals and insiders hold more shares of TLSI or SKIN?

Which has stronger earnings & valuation, TLSI or SKIN?

Summary

How does Beauty Health compare to Shoulder Innovations?

Does the media refer more to SKIN or SI?

Do analysts recommend SKIN or SI?

Is SKIN or SI more profitable?

Do institutionals and insiders hold more shares of SKIN or SI?

Which has higher valuation and earnings, SKIN or SI?

Summary

How does Beauty Health compare to Sight Sciences?

Which has stronger valuation & earnings, SKIN or SGHT?

Which has more risk and volatility, SKIN or SGHT?

Does the media prefer SKIN or SGHT?

Do analysts prefer SKIN or SGHT?

Is SKIN or SGHT more profitable?

Do insiders & institutionals hold more shares of SKIN or SGHT?

Summary

How does Beauty Health compare to Carlsmed?

Which has stronger valuation & earnings, SKIN or CARL?

Does the media favor SKIN or CARL?

Do analysts prefer SKIN or CARL?

Is SKIN or CARL more profitable?

Do insiders & institutionals hold more shares of SKIN or CARL?

Summary

How does Beauty Health compare to Profound Medical?

Does the media favor PROF or SKIN?

Do institutionals & insiders hold more shares of PROF or SKIN?

Which has more volatility and risk, PROF or SKIN?

Do analysts rate PROF or SKIN?

Is PROF or SKIN more profitable?

Which has preferable earnings and valuation, PROF or SKIN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKIN vs. The Competition

Beauty Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools